6 European Projects Found
Searched on 125080 European Projects
FINISHED
ERA-NET: Aligning national/regional translational cancer research programmes and activities (TRANSCAN-2)
Start date: Jan 1, 2015, End date: Dec 31, 2019,
Cancer is a worldwide health burden and represents a major public health challenge in Europe. It is responsible for 25% of all deaths, being the second most common cause of death after cardio-vascular diseases and the main cause of mortality among people aged 45–64. Today, an estimated 9 million individuals in Europe live with cancer (Globocan 2008, http://globocan.iarc.fr/). Cancer became a chron ...
Read Project
30
Partners Participants
FINISHED
Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy (MAGICBULLET)
Start date: Jan 1, 2015, End date: Dec 31, 2018,
Many tumor cells are characterized by the overexpression of certain antigens. Molecules that specifically recognize these structures are suitable as homing devices in tumor therapy. Conjugates of anticancer drugs with such a delivery vector targeting tumors would be a “magic bullet” according to the Nobel laureate Paul Ehrlich. Three antibody-drug conjugates (ADC) have already been approved for an ...
Read Project
9
Partners Participants
FINISHED
A European Platform for Translational Cancer Research (EUROCANPLATFORM)
Start date: Jan 1, 2011, End date: Dec 31, 2016,
Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the increasing burden posed by cancer. The FP6 Eurocan+Plus project analysed the barriers underlying the increasing fragmentation of cancer research and stressed the need to improve collaboration between basic/preclinical and comprehensive cancer centres (CCCs), in ...
Read Project
29
Partners Participants
FINISHED
Roles of Hydrogen Sulfide and its Metabolites in Neutrophil Function and Redox Signaling (NHS)
Start date: Jun 1, 2011, End date: May 31, 2015,
"Inflammation is a fundamental pathological event, which is described as a protective response to abnormal stimulus. However it is also responsible for a plethora of inflammatory diseases. A major role of hydrogen sulfide is suggested in inflammation, but published results are controversial. In large quantities it is toxic, but it is also produced inside the body during the metabolism of the amino ...
Read Project
1
Partner Participant
FINISHED
ERA-NET on Translational Cancer Research (TRANSCAN)
Start date: Jan 1, 2011, End date: Dec 31, 2014,
"Cancer is a worldwide health burden and a major public health challenge in Europe, responsible for 25% of all deaths; a situation expected to worsen with population ageing. The strengthening of translational cancer research is an urgent need in European cancer research, i.e. the integration of basic, epidemiological, preclinical and clinical research with the implementation and evaluation of inte ...
Read Project
29
Partners Participants
FINISHED
Regionale Zusammenarbeit für Ionentherapie (RegIonCo)
Start date: Jun 30, 2008, End date: Mar 30, 2012,
Nahe der österreichisch-ungarischen Grenze wird in Wiener Neustadt die mitteleuropäische Ionenbestrahlungsanlage MedAustron errichtet, die einerseits der Behandlung von Tumorpatienten dient, andererseits klinische und nichtklinische Forschungsaktivitäten ermöglichen soll. Um die positiven regionalen Auswirkungen dieser medizinischen Hightech-Anlage optimal nutzen zu können, erfolgt im Rahmen des ö ...
Read Project
